About IRRAS

Company Description

Founded in Sweden in 2012, IRRAS is a commercial medical device company, focused on designing, developing, and commercializing innovative solutions that transform fluid management after surgical procedures. Our initial clinical focus is on intracranial procedures, where excess cerebrospinal fluid (CSF) often needs to be drained and intracranial pressure (ICP) needs to be closely regulated.

IRRAS’ first commercial product, IRRAflow®, is a next generation intracranial fluid exchange system that consists of a patented dual lumen catheter and control unit with proprietary software that work together to manage the drainage of excess fluid, intelligently manage the regulation of the patient’s ICP, and, on a regular basis, proactively flush the catheter to prevent occlusions from forming.

Year founded

2012

Served area

Europe and USA

Headquarters

Vasagatan 16, 11120 Stockholm – Sweden

Shareholder information

Shares outstanding

66,281,340

IPO

Jan. 1, 2000

Stock exchange(s)

Nasdaq Stockholm

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.